Democratising the treatment of depression through novel, cost-effective fDCS techniques
| Reference number | |
| Coordinator | Flow Neuroscience AB |
| Funding from Vinnova | SEK 500 000 |
| Project duration | July 2017 - January 2018 |
| Status | Completed |
Important results from the project
This project was conducted to perform a feasibility study into the commercial and technical viability of a depression treatment based on transcranial direct current stimulation (tDCS) and digital therapy, at home. The goal was to analyse the market opportunity and the patients´ response to the product from a usability perspective.
Expected long term effects
- The product was found to be commercially viable with demonstrated demand from a large and reachable target market of end-users who are willing to pay for its services. - Usability trials showed a positive response from potential users and valuable feedback was collected.
Approach and implementation
- The demand for the product was measured using sales tests online. Traffic was directed toward landing pages and different metrics were collected. - Usability trials where users were exposed to the product was also conducted and feedback was collected.